Alzamend Non Operating Income Net Other from 2010 to 2026
| ALZN Stock | USD 1.65 0.02 1.23% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 3.6 K | Current Value 3.4 K | Quarterly Volatility 28.9 K |
Check Alzamend Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alzamend Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.4 K, Selling General Administrative of 3.3 M or Other Operating Expenses of 6.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.65. Alzamend financial statements analysis is a perfect complement when working with Alzamend Neuro Valuation or Volatility modules.
Alzamend | Non Operating Income Net Other | Build AI portfolio with Alzamend Stock |
Evaluating Alzamend Neuro's Non Operating Income Net Other across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Alzamend Neuro's fundamental strength.
Latest Alzamend Neuro's Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of Alzamend Neuro over the last few years. It is Alzamend Neuro's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alzamend Neuro's overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Alzamend Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | 41,742 | |
| Geometric Mean | 23,306 | |
| Coefficient Of Variation | 69.13 | |
| Mean Deviation | 26,757 | |
| Median | 62,418 | |
| Standard Deviation | 28,857 | |
| Sample Variance | 832.7M | |
| Range | 59K | |
| R-Value | (0.83) | |
| Mean Square Error | 276.3M | |
| R-Squared | 0.69 | |
| Significance | 0.000037 | |
| Slope | (4,743) | |
| Total Sum of Squares | 13.3B |
Alzamend Non Operating Income Net Other History
About Alzamend Neuro Financial Statements
Alzamend Neuro investors utilize fundamental indicators, such as Non Operating Income Net Other, to predict how Alzamend Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | 3.6 K | 3.4 K |
Pair Trading with Alzamend Neuro
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alzamend Neuro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will appreciate offsetting losses from the drop in the long position's value.Moving against Alzamend Stock
The ability to find closely correlated positions to Alzamend Neuro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alzamend Neuro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alzamend Neuro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alzamend Neuro to buy it.
The correlation of Alzamend Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alzamend Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alzamend Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alzamend Neuro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alzamend Neuro Correlation against competitors. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Biotechnology sector continue expanding? Could Alzamend diversify its offerings? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alzamend Neuro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alzamend Neuro's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alzamend Neuro represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alzamend Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.